Consortium

Institutions

UCIBIO-NOVA

The Research Unit on Applied Molecular Biosciences (UCIBIO) combines key expertise in Chemistry and Biological Sciences with an ambitious strategic plan to maximize its national and international impact in terms of scientific productivity, advanced training and translation to society. In the national context, UCIBIO’s key strength lies on its broad scope of fundamental and applied research, standing at the interface of Chemistry, Biology and Engineering to address pertinent questions at atomic, molecular, sub-cellular and cellular levels, including cell-to-cell interactions and population evolutionary dynamics. More

The UCIBIO’s Strategic Scientific Plan is built around 6 general goals:

Produce and disseminate high quality research;
Increase the societal impact of the basic and applied research developed;
Strengthen existing training programs and activities and offer new ones;
Secure increased funding and internationalization;
Fortify the translation of Biomolecular research to industry and society;
Expand communication to the general public.

LUMC

Leids University Medisch Centrum (LUMC) was founded in 1575 and is one of the leading international research universities in Europe. The LUMC originated from a collaboration between the Academic Hospital Leiden and the Faculty of Medicine of Leiden University.

The Center for Proteomics and Metabolomics (CPM) is the technological core innovator and service provider at the LUMC regarding the analysis of proteins, metabolites, lipids and glycans from biological materials such as cells and tissues. Mass spectrometry is the key technology applied at the CPM, complemented by nuclear magnetic resonance (NMR) and advanced, miniaturized separation systems. The CPM develops and implements cutting-edge proteomics and metabolomics technology for analyzing disease-associated molecular mechanisms and fingerprints within all research themes of the LUMC promoting technological innovation, biomedical research and public health. More

CIC bioGUNE

CIC bioGUNE, member of the Basque Research and Technology Alliance (BRTA), is a key research center within the national and international scientific landscape and has emerged as a knowledge source in the area of health science. The cutting-edge scientific activity of CIC bioGUNE researchers explores the interface between Chemistry, Structural, Molecular and Cell Biology, with the aim of developing a more Precise Medicine for the future.

CIC bioGUNE has modern scientific infrastructures, led by prestigious scientists, which allow it to compete with the main European research institutes. These include advanced equipment for nuclear magnetic resonance (NMR), electron microscopy and X-ray diffraction, as well as different core technology platforms where genomes, proteomes and metabolomes can be analyzed. Two research programmes - "Molecular Recognition and Host-Pathogen Interactions" and "Metabolism and Cell Signaling in Disease" – are made up of more than a hundred scientists and technicians who concentrate on the molecular bases and mechanisms of disease to create new diagnostic methods and promote development of advanced therapies. More

IMPERIAL

Imperial College London is a world top ten university with an international reputation for excellence in teaching and research. It is committed to developing the next generation of researchers, scientists and academics through collaboration across disciplines.

The Imperial’s Glycosciences Laboratory consists of a team with expertise in glycobiology, glyco-analytics, glyco-chemistry, glycoinformatics, and immunochemistry. Their mission is the elucidation of carbohydrate recognition systems of biological and medical importance. Their speciality is the discovery of glycan ligands for proteins involved in innate and acquired immunity and pathogen-host interactions, also the characterization of developmentally-regulated and cancer associated antigens. The Glycosciences Laboratory possesses a library of carbohydrate materials, currently one of the largest and most diverse worldwide, and a state-of-the-art Carbohydrate Microarray Facility with a mass spectrometry laboratory for glycan sequencing. The facility offers microarray screening analyses for carbohydrate-recognition systems and follow-on collaborations to the broad scientific community. More

Coordinators

Paula Videira

Paula Videira is the Group leader of Glycoimmunology Group at UCIBIO and an Associate Professor at NOVA School of Science and Technology (NOVA FCT). She coordinates the CDG&Allies-PPAIN and is also the co-founder at CellmAbs Biopharmaceutical.

Angelina Palma

Angelina Palma is the leader of the Functional Glycobiology Lab (GlycoLab) at UCIBIO, and an Assistant Professor at NOVA School of Science and Technology (NOVA FCT).

Filipa Marcelo

Filipa Marcelo is the co-leader of the (Bio)Molecular Structure and Interactions by NMR Lab (BioNMR Lab) at UCIBIO, in NOVA School of Science and Technology (NOVA FCT).